HCA Healthcare, Inc.'s Stock Analysis

HCA Healthcare Issues $3 Billion in Senior Notes

HCA Healthcare's subsidiary, HCA Inc., has completed a public offering of $3 billion in senior notes, which includes $1 billion in 4.700% notes due in 2031, $750 million in 5.000% notes due in 2033, and $1.25 billion in 5.300% notes due in 2036. These notes are guaranteed on a senior unsecured basis by HCA Healthcare and have been registered under the Securities Act. The interest on these notes will be paid semi-annually, starting November 15, 2026, and the notes rank senior to subordinated debts but are subordinated to secured debts of the company’s subsidiaries.

The indentures associated with these notes include covenants that limit the company's ability to create liens and engage in certain transactions, as well as stipulations for optional redemption and events of default. Additionally, in the event of a qualifying ratings downgrade and specific changes of control, holders of the notes can require the issuer to repurchase their notes at a premium. The issuance was facilitated through an underwriting agreement with major financial institutions, indicating a structured approach to raising capital.

Apr 30, 2026 16:10:19

HCA Healthcare Annual Meeting Results and Voting Outcomes

HCA Healthcare held its Annual Meeting of Stockholders on April 23, 2026, with 209,777,472 shares represented out of 223,568,966 total shares entitled to vote. Nine director nominees were elected to the Board of Directors for a one-year term, and Ernst & Young LLP was ratified as the independent registered public accounting firm for the year ending December 31, 2026.

Additionally, stockholders approved a non-binding advisory resolution on executive officer compensation. However, two stockholder proposals, one regarding a report on healthcare consequences and another concerning shareholders' right to act by written consent, were not approved.

Apr 28, 2026 16:20:43

HCA Healthcare Announces Senior Notes Offering and Redemption Plans

HCA Healthcare, Inc. announced the commencement of a public offering of senior unsecured notes by its wholly owned subsidiary, HCA Inc. The actual terms of the offering, including maturity and interest rates, will depend on market conditions. The proceeds from the offering are intended for general corporate purposes, which may include repaying outstanding borrowings under its commercial paper program and redeeming certain senior notes due in June and September 2026.

On April 27, 2026, HCA Inc. notified that it will redeem $1.5 billion of its 5.250% senior notes due June 2026 and $1 billion of its 5.375% senior notes due September 2026, with the redemption scheduled for May 27, 2026. This redemption is contingent upon the receipt of net proceeds from the offering. The offering is being managed by Citigroup, Barclays, BofA Securities, and J.P. Morgan, and is conducted under an effective shelf registration statement filed with the SEC.

Apr 27, 2026 16:41:04

HCA Healthcare Reports Q1 2026 Financial Results and Dividend

HCA Healthcare, Inc. announced its financial results for the first quarter of 2026, reporting revenues of $19.109 billion, a 4.3% increase from the previous year. Net income attributable to the company rose by 0.6% to $1.620 billion, translating to a diluted earnings per share of $7.15, which is a 10.9% increase. The company noted a 22% increase in cash flows from operating activities, totaling $2.014 billion, and a slight increase in same facility admissions by 0.9%. However, there were declines in inpatient and outpatient surgeries, attributed to lower respiratory-related admissions due to seasonal factors and a winter storm impacting volumes in certain markets.

Additionally, HCA Healthcare's Board of Directors declared a quarterly cash dividend of $0.78 per share, set to be paid on June 30, 2026, to stockholders of record by June 16, 2026. The company reported total assets of $61.450 billion and total debt of $48.023 billion as of March 31, 2026. HCA also indicated that it had $9.179 billion remaining under its stock repurchase authorization, having repurchased over 3 million shares in the first quarter.

Apr 24, 2026 07:11:37

HCA Healthcare Announces 2026 Executive Performance Program Details

HCA Healthcare has established the 2026 Executive Officer Performance Excellence Program, which allows executive officers to earn performance awards based on specific targets. The program allocates 80% of the award potential to EBITDA targets and 20% to quality metrics, including healthcare-associated infections, complications, and care experience. Payments will be made in cash, with no awards for performance below minimum thresholds, and the Compensation Committee retains discretion to adjust terms based on unusual events or changes in quality metrics definitions.

Additionally, Robert J. Dennis will retire from the Board of Directors effective April 23, 2026, as he will not seek re-election. This change in leadership may impact the company's governance structure going forward. The details of the Executive Officer PEP and the board transition are relevant for investors monitoring executive compensation strategies and corporate governance developments.

Feb 25, 2026 16:43:45

HCA Healthcare Reports Q4 2025 Financial Results and Updates

HCA Healthcare reported a revenue increase of 6.7% for the fourth quarter of 2025, totaling $19.513 billion, alongside a 30.6% rise in net income to $1.878 billion. Diluted earnings per share rose to $8.14, up 44.6% from the previous year. The company also noted gains on sales of facilities, contributing positively to its financial performance. For the entire year, revenues reached $75.600 billion, with net income of $6.784 billion, reflecting overall growth compared to 2024.

The Board of Directors has authorized a $10 billion share repurchase program and declared a quarterly cash dividend of $0.78 per share, set for payment on March 31, 2026. As of December 31, 2025, HCA Healthcare held $1.040 billion in cash and cash equivalents, with total debt at $46.492 billion. The company plans capital expenditures between $5.0 billion and $5.5 billion for 2026, indicating ongoing investments in its operations.

Jan 27, 2026 07:12:53

HCA Healthcare Issues $3.25 Billion in Senior Notes

HCA Inc., a wholly owned subsidiary of HCA Healthcare, has completed a public offering of $3.25 billion in senior notes, which includes four series with varying maturities and interest rates. The notes consist of $500 million due in 2030 at 4.3%, $1 billion due in 2032 at 4.6%, $1 billion due in 2035 at 4.9%, and $750 million due in 2055 at 5.7%. These notes are guaranteed on a senior unsecured basis by HCA Healthcare and will pay interest semi-annually starting May 15, 2026.

The notes rank senior in payment to any existing subordinated debt but are subordinated to any secured debt. The indentures include covenants that limit the issuer's ability to incur additional debt or engage in significant asset transactions. Additionally, in the event of a ratings downgrade and certain changes of control, noteholders have the right to require repurchase of their notes at a premium. The offering was facilitated through an underwriting agreement with several financial institutions.

Oct 31, 2025 16:15:19

HCA Healthcare Announces Public Offering of Senior Unsecured Notes

HCA Healthcare, Inc. has announced a proposed public offering of senior unsecured notes through its wholly owned subsidiary, HCA Inc. The offering is subject to market conditions, with the actual terms including maturity and interest rate to be determined at pricing. The net proceeds from this offering are intended for general corporate purposes, which may include repaying outstanding borrowings under its commercial paper program and redeeming its existing 5.875% senior notes due 2026.

On October 27, 2025, HCA Inc. notified of its intention to redeem all $1.5 billion of its 5.875% senior notes, contingent upon receiving the proceeds from the offering prior to the redemption date of November 26, 2025. The offering is being managed by several financial institutions, and additional details are available through the SEC's website and the respective managers. This announcement does not constitute an offer to sell or a solicitation to buy the senior notes.

Oct 27, 2025 16:16:44

HCA Healthcare Reports Q3 2025 Financial Results and Dividend

HCA Healthcare, Inc. announced its financial results for the third quarter of 2025, reporting revenues of $19.161 billion, a 9.6% increase from the previous year. Net income attributable to the company rose by 29.4% to $1.643 billion, translating to diluted earnings per share of $6.96, which is a 42.6% increase compared to Q3 2024. The company also noted an increase in same facility admissions and a significant rise in cash flows from operating activities, totaling $4.416 billion for the quarter.

Additionally, HCA's Board of Directors declared a quarterly cash dividend of $0.72 per share, set to be paid on December 29, 2025, to stockholders of record by December 15, 2025. The company updated its 2025 guidance, estimating capital expenditures of approximately $5.0 billion for the year, reflecting ongoing investments in operational improvements and technology. As of September 30, 2025, HCA Healthcare had total assets of $59.747 billion and total debt of $44.511 billion.

Oct 24, 2025 07:16:56

HCA Healthcare Reports Q2 2025 Results and Dividend Declaration

HCA Healthcare, Inc. announced its financial results for the second quarter of 2025, reporting revenues of $18.605 billion, a 6.4% increase from the same period in 2024. Net income rose to $1.653 billion, or $6.83 per diluted share, marking a 13.1% increase year-over-year. The company also reported an 8.4% increase in Adjusted EBITDA to $3.849 billion and significant growth in cash flows from operating activities, which totaled $4.210 billion compared to $1.971 billion in Q2 2024. Same facility admissions and equivalent admissions showed modest increases of 1.8% and 1.7%, respectively, while emergency room visits also increased slightly by 1.3%.

Additionally, HCA's Board of Directors declared a quarterly cash dividend of $0.72 per share, set to be paid on September 30, 2025, to stockholders of record by September 16, 2025. The company has $5.753 billion remaining under its share repurchase authorization and estimates capital expenditures of approximately $5.0 billion for the year. As of June 30, 2025, HCA had total assets of $59.536 billion and total debt of $44.483 billion, indicating a solid financial position amidst ongoing operations.

Jul 25, 2025 07:46:01